FDA approves Astellas’ leaky bladder drug

The FDA has approved Astellas’ new overactive bladder disorder drug Myrbetriq.   Myrbetriq (mirabegron), the first drug in its class, works by activating a protein receptor in bladder…
Read the full story: InPharm